Watchlist

Watchlist
Aratana Therapeutics, Inc. (PETX)
Aratana Therapeutics, Inc. (PETX)
Aratana Therapeutics: What Does It Have In Store For The Investors?
What does Aratana Threapeutics (PETX) do? Aratana Therapeutics, a US based pet therapeutics company, formed in 2010, belonging to the Health Care industry. The company focuses on developing, licensing and commercializing innovative therapies for the health of animals predominantly dogs and…
Your Daily Pharma Scoop: Loxo Data, GW Pharmaceuticals' Q4 Results, Zynerba Positive Data
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Total Pharma Tracker subscribers get the full version with actionable ideas one …
Biotech Forum Daily Digest: Some Recent Positives For Egalet
The road that is built in hope is more pleasant to the traveler than the road built in despair, even though they both lead to the same destination . - Marion Zimmer Bradley, The Fall Of Atlantis Biotech continues to be directionless in trading. The main biotech indices are close t…
Premarket Gainers as of 9:05 am
CAPR +29% as FDA signs off on registration study of Capricor's DMD candidate CAP-1002. More news on: Capricor Therapeutics, Inc., Digital Power Corporation, Marathon Patent Group, Inc., Stocks on the move, Read more …
Aratana Therapeutics, Inc. Announces Termination of Offering of Common Stock
LEAWOOD, Kan. , Nov. 28, 2017 /PRNewswire/ --Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative therapeutics for dogs and cats, today announced that it has terminated the offering of shares of its com…
Midday Gainers / Losers
Gainers: APEN +53% . CREG +33% . OHGI +20% . OTCPK:OMNT +21% . COOL +16% . TEUM +14% . SMIT +14% . THO +13% . QNST +12% . OTCQB:MRDN +11% . More news on: Apollo Endosurgery, China Recycling Energy Corporation, One Horizon Group, Inc., Stocks on t…
Aratana Therapeutics, Inc. Announces Proposed Public Offering
LEAWOOD, Kan. , Nov. 27, 2017 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative therapeutics for dogs and cats, today announced that it is commencing an underwritten registered public offer…
Your Daily Pharma Scoop: Heron Undervalued, Theravance Submits NDA, Nektar Continues To Surge
This abridged "Daily Scoop" is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Heron Therapeutics Today we will discuss an article …
Your Daily Pharma Scoop: Regeneron's Appeal, Good News For Amgen, Bristol-Myers' Sprycel
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Regeneron Today we will dis…
European advisory group backs Aratana's Galliprant; shares ahead 2%
The European Medicines Agency's Committee for Medicinal Products for Veterinary Use (CVMP) adopts a positive opinion recommending approval for Aratana Therapeutics' ( PETX +1.7% ) GALLIPRANT (grapiprant tablets) for the treatment of pain associated with mild-to-moderate osteoarthritis in…
Elanco, Aratana Announce Positive Opinion on GALLIPRANT® (grapiprant tablets) in Europe
LEAWOOD, Kan. , Nov. 10, 2017 /PRNewswire/ --Elanco Animal Health, a division of Eli Lilly and Company (NYSE: LLY) and Aratana Therapeutics, Inc. (NASDAQ: PETX), today announced the European Medicine Agency's (EMA) Committee for Medicinal Products for Veterinary Use (CVMP) adopted a…
Aratana Therapeutics, Inc. (PETX)